Major Insurers Scale Back Medicare Advantage Plans Amid Reimbursement Cuts
PorAinvest
jueves, 2 de octubre de 2025, 11:16 am ET1 min de lectura
CVS--
UnitedHealth Group shares declined in premarket trading on Wednesday after the health insurer announced plans to cancel its Medicare Advantage offerings in 109 U.S. counties in 2026 [1]. The decision comes as UnitedHealth and its peers, Humana and CVS Health, move to scale back their Medicare Advantage presence amid mounting cost pressures and lower federal reimbursements.
Bobby Hunter, head of UnitedHealth’s government programs, stated during a Tuesday press briefing that the combination of Centers for Medicare and Medicaid Services (CMS) funding cuts, rising healthcare costs, and increased utilization has created headwinds that no organization can ignore [1]. UnitedHealth will continue operating in most U.S. states and remains the largest Medicare Advantage provider nationwide, ahead of Humana and CVS’s Aetna business.
Humana and CVS Health’s Aetna are also reducing their Medicare Advantage offerings. Aetna will offer plans in 43 states and Washington D.C., one fewer than this year, while Humana will cover only 85% of U.S. counties next year, down from 89% this year [2]. These moves follow a challenging year for Medicare-focused insurers, which faced higher-than-expected service utilization and lower government payments.
The stock market has reacted to these announcements, with retail sentiment for UnitedHealth and CVS Health being 'bearish' on Stocktwits, while Humana's sentiment was 'neutral' amid 'high' activity [1]. UnitedHealth's stock has fallen 30% so far this year, while Humana is down 2%, and CVS Health has surged 77%.
HUM--
UNH--
Major health insurers, including UnitedHealth, Humana, and CVS Health's Aetna, are scaling back their Medicare Advantage offerings in 2026 due to government reimbursement cuts and increased medical costs. UnitedHealth will stop operating in 109 counties, affecting 180,000 people, while Humana will reduce availability to 85% of counties, down from 89% this year. The insurers are also exiting some states altogether.
Major health insurers, including UnitedHealth, Humana, and CVS Health's Aetna, are scaling back their Medicare Advantage offerings in 2026 due to government reimbursement cuts and increased medical costs. UnitedHealth will stop operating in 109 counties, affecting approximately 180,000 people, while Humana will reduce availability to 85% of counties, down from 89% this year. The insurers are also exiting some states altogether.UnitedHealth Group shares declined in premarket trading on Wednesday after the health insurer announced plans to cancel its Medicare Advantage offerings in 109 U.S. counties in 2026 [1]. The decision comes as UnitedHealth and its peers, Humana and CVS Health, move to scale back their Medicare Advantage presence amid mounting cost pressures and lower federal reimbursements.
Bobby Hunter, head of UnitedHealth’s government programs, stated during a Tuesday press briefing that the combination of Centers for Medicare and Medicaid Services (CMS) funding cuts, rising healthcare costs, and increased utilization has created headwinds that no organization can ignore [1]. UnitedHealth will continue operating in most U.S. states and remains the largest Medicare Advantage provider nationwide, ahead of Humana and CVS’s Aetna business.
Humana and CVS Health’s Aetna are also reducing their Medicare Advantage offerings. Aetna will offer plans in 43 states and Washington D.C., one fewer than this year, while Humana will cover only 85% of U.S. counties next year, down from 89% this year [2]. These moves follow a challenging year for Medicare-focused insurers, which faced higher-than-expected service utilization and lower government payments.
The stock market has reacted to these announcements, with retail sentiment for UnitedHealth and CVS Health being 'bearish' on Stocktwits, while Humana's sentiment was 'neutral' amid 'high' activity [1]. UnitedHealth's stock has fallen 30% so far this year, while Humana is down 2%, and CVS Health has surged 77%.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios